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ThePalmaz Intravascular Stent and the Auth Rotablator
are two promising developments in the treatment of Peripheral
Vascular Disease (PVD), which is defined by limited blood flow to the body
outside of coronary circulation due to vascular obstruction. These obstruc
tions are caused by the fatty lesions that characterize atherosclerosis. So, to
better understand this technology, this paper will first examine the biologi
cal mechanisms contributing to the formation of the atherosclerotic lesions
that cause PVD.
Atherosclerosis, a form of arteriosclerosis (hardening of the arteries),
is a condition evidenced by the formation of arterial plaque due to a combi
nation of changes in the tunica intima of a vessel. Accumulations of plaque,
or lesions, increase in size over time and begin to decrease the diameter of
the vessel's lumen, impeding blood flow. The mechanism of development for
these plaques is theorized to be triggered by some form of damage to the
endothelium of the vessel (R. Ross p488). After this initial damage, further
events contribute to lesion formation, such as the accumulation and infiltra
tion of Low-density Lipoprotiens (LDL's), the accumulation of platelets and
clotting factors, and the proliferation and migration of smooth muscle cells
into the lumen. It is, however, that initial endothelial damage that allows
these secondary contributions to take place.
The endothelium is a simple squamous epithelial sheet, one cell thick,
lining the lumen of a healthy artery. These elongated squamous cells are
positioned with their long axis parallel to the direction of arterial flow and
are joined by junctional complexes, making them extremely adherent to each
other. These qualities make the endothelium, coupled with the basement
membrane a strong, frictionless barrier against the passage ofmaterial
across the artery wall (M. Ross p285-6). Damage to this barrier, which may
occur due to a number of factors, is the first step toward the development of
an atherosclerotic lesion.
Endothelial damage may occur simply due to mechanical stress, like
that caused by the constant pressure of hypertension, or chemical stress,
such as that caused by the toxins of cigarette smoke (Porth p358). Damage
can also occur, in a less direct way, due to a limitation of blood supply to the
vessel itself. Every artery has its own vascular network called the vasa vaso-
rum, located in the tunica adventitia of the vessel (M. Ross p287).
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Psychological stress can result in vaso-constriction, and the resulting
ischemia can damage the vessel from the outside inward.
As blood cholesterol levels increase so do interactions between
macrophages and the endothelium. The macrophages move through the
junctional complexes into subendothelial space (Porth p358). This is the ear
liest event in the formation of fatty streaks (R. Ross p493). Fatty streaks are
a premature form of atherosclerotic lesions. Observed in children as young
as ten, they develop in anatomical sites that correlate directly with the more
mature
"fibro-muscular"
atherosclerotic lesions, strongly suggesting a
"precursor -
product"
relationship between the two (R. Ross p488). The
macrophages that migrate below the endothelium have receptors for LDL's.
"It is probable that the capacity of the macrophage to take up these
lipo-pro-
teins and to de-esterify and re-esterify cholesterol may be important to their
ability to accumulate
lipid"
(R. Ross p 493). As this macrophage-mediated
lipid steak grows, it becomes large enough to break apart the intercellular
junctions of the endothelium - much like weeds growing beneath a paved
walk - exposing the subendothelial space (Porth p 358). Regardless of the cir
cumstances of the assault, once the slick, frictionless lining of the lumen is
damaged, platelets accumulate at the sight and atherogenesis is under way.
The endothelium usually prevents the accumulation of platelets due
to its slickness and its ability to form anti-thrombic substances, but any
form of endothelial injury will promote platelet adherence and the release of
clotting factors (R. Ross p492).When activated, platelets release
Thromboplastin (M. Ross pl86). This acts to start a chain reaction which
ultimately results in the production of Fibrin. Subsequently, a fibrous mesh
network entangles platelets and red blood cells over the exposed suben
dothelial tissue, forming a clot (Curtis p752).
Platelets not only provide part of this fibrous component but also trig
ger the production of the muscular component of the lesion. Platelets secrete
at least two growth factors, one ofwhich in particular, platelet-derived
growth factor (PDGF), is significant to atherogenesis. Smooth muscle cells,
located just beneath the basement membrane, have receptors for PDGF.
PDGF is "both chemotactic and mitogenic, and thus can induce both migra
tion and
proliferation"
(R. Ross p492). Therefore, the smooth muscle cells
exposed to platelet accumulation not only reproduce mitoticly but also trans
verse the basement membrane into the clot and undergo further mitosis.
This adds significantly to the mass of the lesion occupying luminal space.
Furthermore, growth factors almost identical to PDGF are released by both
macrophages and endothelial cells, "thus, endothelial injury could result in




p496). LDL's play a role here as well. They may further accumulate due to
LDL receptors present on smooth muscle cells, adding mass to the lesion (R.
Ross p492). LDL's may also be a co-factor in the proliferation of the smooth
muscle (Porth p358).
Interestingly, to compensate for the growth of these lesions, the artery
has developed a natural adaptation. Very large plaques have been found to
exist without impeding on lumen caliber because of the artery's ability to
enlarge itself to limit the stenosing effect of the lesion. "In the human left
main coronary artery, such enlargement keeps pace with increases in intimal
plaque and is effective in preventing lumen stenosis until the area of the
plaque occupies approximately 40% of the cross-sectional
area"
(Ahn VI
p541). The mechanism for such an adaptation is not completely defined but
may involve atrophy and dilation of the uninvolved portion of the wall. This
adaptation, however, is not fail-safe, as these lesions do eventually cause
stenosis. Basically, an artery can enlarge itself to keep pace with the steno
sis, but only to a certain point. After it reaches pathologic proportions, med
ical science has developed ways of correcting the stenosis mechanically. The
placement of a vascular stent, a prosthetic cage which physically holds open
the lumen, and the removal of the lesion through rotational atherectomy are
two such mechanical enhancements of the artery's natural adaptive process.
In conclusion, atherosclerotic lesions develop due to some injury to the
endothelial layer of a vessel. Fatty streaks, the earliest form of these
lesions, are macrophage mediated accumulations of LDL's below the
endothelium and can grow to break apart endothelial junctions. Mature
lesions consist of fatty accumulations, clotting elements, and massive prolif
eration and migration of subendothelial smooth muscle. To compensate for
reduced lumen caliber, arteries have a natural adaptive enlargement process
that is effective but limited, and these natural limits can be expanded
though surgical intervention.
Chapter 1
Attempting to expand the limits of the balloon
The most developed, successful and established minimally inva
sive endovascular treatment of atherosclerosis is the well pub
licized Percutaneous Transluminal BalloonAngioplasty (PTA). PTA utilizes
a catheter consisting of a balloon at the distal end. The balloon, when inflat
ed, dilates vessel stenosis, opening the lumen by redistributing plaque along
the intima, and hydrostatic pressure of the blood flow is relied on to main
tain the new diameter. PTA has been employed to treat stenosis in the coro
nary, aortic, iliac, femoral, popliteal, tibial, mesenteric and renal circulations
(Ahn IV p425).
The benefits of this procedure are impressive. As an adjunct to
surgery it limits the severity of the procedure, saving hundreds of lives and
millions of dollars annually. It holds up to 93% success rates at one year and
92% after two years in common sites of usage, such as the iliac arteries (Ahn
III p292). However, the success rates are much less impressive when certain
variables are introduced into the equation. Most of these variables have to
do with rebound stenosis, the location and tortuosity of the vessel, as well as
the eccentricity and rigidity of the lesion (Topol p858). "The major problem of
restenosis, which occurs in up to 40% of cases [coronary data] after an ini
tially successful procedure, and continuing technical difficulties in dealing
with certain types of lesions (particularly those that are calcified or in distal
locations) have stimulated research into alternative
methods"
(Bertrand
p470). So, it is not the lack of success of PTA but the limitations of that suc
cess that has fueled the need for further development.
Many roads have been taken in the past two decades with the com
mon goal of furthering PTA and therapeutic endovascular technology in gen
eral. Laser angioplasty, introduced in 1982, drew much popular attention.
The public's fascination with the "21st
century"
technology of laser light and
its anticipated applications, in both the lay and scientific worlds, is under
standable, but before these applications can become reality further develop
ment is still required. Laser angioplasty, as of yet, is really Laser-assisted
Balloon Angioplasty (LABA). The laser is only utilized to create a passage
for the guide wire of the balloon catheter if the occlusion is of a severity that
does not already allow passage. Final dilation is still the result of PTA (Ahn
IV p426). Though LABA does allow the treatment ofmany lesions otherwise
untreatable by PTA, guide wires can usually cross occlusions without assis-
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tance, so "the number of patients who require LABA is . . . quite
small"
(Ahn,
IV p426-7). Two drawbacks limit laser angioplasty from wider application:
it's difficulty in safely vaporizing lesions that are calcified and its inability to
discriminate between healthy intima and lesion. Vessel wall perforations
plague the development of laser angioplasty (Ahn III p292). Perhaps this
"21st
century"
technology will actually have to wait until the 21st century
before it realizes its full potential. For now, advancements of a more mechan





The term atherectomy is used to refer to any procedure which
excises the lesion from the vessel, performed with the place
ment of a catheter percutaneously or through an arteriotomy far from the
diseased site. Its technological development has taken many forms. The
Simpson Peripheral Atherocath utilizes an advancing cutter in a metal
housing. A balloon inflates, forcing plaque into the housing where it is
excised (Ahn TV p427). The Trac-Wright catheter works with a rotating
cam tip and high-pressure irrigation. It follows the path of least resistance,
using no guide wire. So, like laser angioplasty it is an ideal pre-PTA proce
dure, burrowing a hole for the balloon catheter's guide wire (Ahn TV p428).
The Transluminal Extraction Catheter removes plaque entering its cone
shaped housing with internal rotating blades. Plaque is aspirated through a
hollow catheter into vacuum bottles (Ahn rV p429).
However, the most recently approved atherectomy device is the focus
of this paper. Designed by DavidAuth, PhD., TheAuth Rotablator, in theo-
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ry, addresses the problems associated with calcified lesions, intimal flaps,
arterial dissections, eccentric lesions and embolism down stream from the
lesion. The Rotablator is an oval-shaped burr that rotates on an axial guide-
wire, while also tracking back and forth along that guide-wire, with the pur
pose of removing a calcified lesion transluminally (Ahn III p293).
The foremost hemisphere of the brass burr is embedded with numer
ous diamond chips each ofwhich acts as a microknife. The chips range from
22 to 45 um (Ahn I p873). These microknives are the key to the rotablator's
design. Because they remove hard material rather than trying to displace it
(like PTA), they are ideal for calcified lesions. Furthermore, because they are
removing the lesion no intimal flaps remain to cause turbulence in blood
flow; the intraluminal surface is left polished and smooth (Ahn III p295).
These microknives also address the problem ofvessel dissection and perfora
tion because, unlike the laser, they are selective cutters. "The differential
cutting of the burr allows it to grind the hard plaque selectively, instead of
the elastic wall of the artery, thus minimizing potential for
perforations"
(C.R.A.G. p509-10). The selectivity relies on the fact that the elastic tissue of
the artery can deflect around the diamond edge while the calcified lesion is
rigid and therefore chopped under the force (Ahn III p293). These cutters
also address the problem of embolism because they pulverize the plaque into
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a colloidal suspension of particles, generally smaller than red blood cells,
which have little potential to embolize (Ahn rV p428). Even in the earliest
studies, particles produced were "generally small enough to go though the
canine capillary circulation to be removed easily by the reticuloendothelial
system"
(C.R.A.G. p510).
All of these characteristics add up to a device that is best suited for
the rigid, calcified lesions common in diabetic patients, as well as the stenot
ic, sometimes eccentric lesions of the popliteal, and superficial femoral arter
ies (Ahn I p874).
Rotational Atherectomy can be done percutaneously or through an
open arteriotomy, however the later is preferred because it does not limit the
burr size to 3mm. Burrs can range from 1.25mm to 6.0mm and are chosen in
relation to the diameter of the vessel (Ahn I p874).
Before the procedure, lesions are documented, sometimes endoscopicly
and always angiographicly.Ankle/brachial indices, a comparison of blood
pressure in the arm (unaffected by the lesion), and the ankle (affected by the
lesion), are also taken. All data is taken with the purpose of post-treatment
comparison in the determination of success (C.R.A.G. p510). Drug treatment
consists of 24 to 48 hours of an intravenous Dextran/Papaverine combination
for the purpose of expanding plasma volume (Ahn II p273).
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The procedure begins with the insertion of an introducer sheath: 7, 9,
12 or 14 French. A small atraumatic guide wire is passed through the lesion.
This small guide wire is replaced by a more rigid .009 inch guide wire with
the aid of an exchange guide catheter.With the original guide wire and the
exchange guide catheter removed, the burr is passed over the remaining
rigid guide wire to the site of the lesion. Rotation is now activated (Ahn I
p874-5).
The drive shaft, encased in a protective, flexible plastic sheath, is con
nected to a turbine driven by compressed air.Air pressure which controls the
rpm's is in turn controlled by the surgeon through a pedal or a dial. A sliding
knob, controlling the advance and retreat of the burr, is controlled by the
surgeon on the top of the turbine casing. A pin-vise, controlling the guide
wire orientation is located on the proximal end of the turbine casing (Ahn III
p923). Maintaining speeds of 100,000 to 200,000 rpm's the burr is advanced
slowly into the lesion in a "vibrato-like to-and-fro manner". A small diameter
burr is initially used and replaced sequentially by larger burrs over the
same guide wire (Ahn I p875). This process is continued until recanalization,
defined as the residual stenosis being less than 25% smaller than the lumi
nal diameter of the normal native vessel, is achieved (C.R.A.G. p510). The
rotary time ranges from 30 sec. to 35 min., and the entire procedure may
15
last between 15 minutes and 2 hours (C.R.A.G. p510).
After the procedure, the patient is placed on anti-coagulation drugs
for 24 hours and aspirin long term (Ahn I p875). Post-operative physical
exams include ankle/brachial indices at various follow-up intervals and pos
sibly continued angiography (C.R.A.G. p510).
Success in each of two series of studies (one at Stanford, one at
UCLA) was defined in three categories. "Intraoperative arteriographic suc
cess"
is defined as the "reduction of the lesion to a residual stenosis of less
than 25% with no significant intimal flaps, dissections or perforations visu
alized by intraoperative
radiography"





combined with postoperative improve
ment of ankle/brachial indices by greater than .15, the presence of a palpable
pulse distal to the atherectomy, and improved capillary refill, skin color and
warmth. "Late
success"
is defined as persistence of all above criteria (Ahn II
p274).
The UCLA study reported a 93% success rate of the
"Intraoperative"
nature (Ahn II p274). Although the Stanford study showed only a 77%
"Intraoperative"
success rate, it increased to 84% when confined to the
superficial femoral artery, the site most suited for rotational atherectomy
(C.R.A.G. p511). The
"In-hospital"
rate was lower, with the UCLA figure
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dropping to 72%. This is slightly disappointing but not tragic as the numbers
were equal to or better than those of the other atherectomy devices (Ahn II
p276) (C.R.A.G. p513). Furthermore, many failures were seen as preventable
in the future through more careful procedures (C.R.A.G. p 513).
Long-term patency, however, is currently the largest obstacle facing
the Rotablator. It certainly lives up to its billing as a specialized cutter; "the
lack of perforation and late aneurysmal changes in the current study were
predicted . . . and suggest that the elastin fibers of the arterial wall remain
intact"
(Ahn II p279). However, its ability to create an lumen that remains
open for a significant length of time is currently very suspect, as "Late suc
cess"
data was very disappointing. Primary patency rates were as low as
9.5% after two years in the UCLA study (Ahn I p875). In the Stanford study
most of the restenosis or reocclusion occurred within a year (C.R.A.G. p515).
Both studies lean toward the belief that this failed long-term patency lies
mostly in hyperplasia of the intima, rather than rethrombosis, because,
though the intima is never lacerated, it can become denuded during the pro
cedure. Timing of the failed patency as well as direct visual documentation
of hyperplasia supports this conclusion (Ahn II p 279).
Though it does fulfill some of its design's promises (eliminating most
calcified lesions without dissecting or perforating the vessel) the feeling
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remains that the Rotablator, at this stage in its development, may not signif
icantly improve long-term patency. Both the UCLA and Stanford studies see
the overall results as disappointing, saying, the Rotablator is not yet clinical
ly effective. Recent writings by Samuel S.Ahn, M.D. (Associate Clinical
Professor of Surgery, UCLA Center for Health Sciences) and his colleague
Darwin Eton, M.D., F.A.C.S. (Associate Professor of Surgery, Division of
Vascular Surgery at the University of Southern California) acknowledge
long-term patency limitations caused by recurrent stenosis secondary to
neointimal hyperplasia as "the major obstacle major obstacle to more
widespread use of atherectomy
technology"
(Ahn V p502). However, they also
stress that it is too soon to know for sure, implying that not enough data
has been collected for a truly accurate picture of the technology's effective
ness. They write, "As this technology evolves and patient acrual increases,
the restenosis rate will be better
defined"
(AhnV p502).With support for the
technology, M.R. Balaji, M.D., FA.C.S. (Clinical Associate Professor of
Surgery University ofRochester) explains that his personal experience with
the Rotablator has been more promising. He states that shorter lesions are
better suited for RotationalAtherectomy, and selecting lesions more suitable
to the procedure yields better results. At any rate, no authority is ready to
bury the technology, agreeing that its potential benefits warrant further
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development and clinical testing.
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Chapter 2
The Palmaz Intravascular Stent
When the vascular question is long-term patency, the techno
logical answer may very well be intravascular stents.
Reclosure rates, either very abrupt or after a short time, still damage PTA
statistics, and, as discussed in the previous chapter, atherectomy is not yet
the answer to that problem. Stents are intravascular prosthetics, usually
coils or cages, introduced to the vessel percutaneously, which expand the
lumen and then remain as long-term physical supports of optimal patency.
Two major causes of reclosure are intimal dissection and elastic recoil
(Katzen p942). It is the long-term physical presence of a stent that is the
key to addressing these problems (Ahn rV p429). "Intravascular stents pro
vide a mechanical means to overcome elastic recoil and to compress the
plaque and intimal dissections against the wall creating a more rounded
vascular
channel"
(Katzen p942). The opposition of recoil also eliminates the
need for the surgeon to overdilate the vessel (Palmaz p730). Over a period of
four to six weeks, the stent actually becomes integrated into the intima of
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the vessel, covered with a true endothelium that in studies thus far seems to
be free from the atherosclerotic process (Katzen p492). "The smooth and reg
ular lumen obtained should decrease or prevent the development of luminal
irregularities after angioplasty (Palmaz p 730). Furthermore, the stents
long-term hold on lesion works in the prevention of intimal flaps and emboli
(Ahn VI p542).
The idea of percutaneously placing a spiral stent was introduced in
1969 by Charles Dotter, the man who introduced PTA to the scientific com
munity five years prior (Zollikofer p272). Interestingly, he actually touched
on the concept of stenting in that earlier paper on PTA (Katzen p941). The
lack of technology and interest, however, delayed further development of the
idea until circa 1980. It was then that Dr. Maass and group of scientists
began experimenting with a self-expanding spring coil at the University of
Zurich (Zollikofer p723). It is from this point that the development of stent
ing, like that of atherectomy, begins to take many paths. By 1988 a number
ofvariations on the concept were being reported ranging from permanent to
temporary, from self-expanding to balloon-expanding, from metallic to non-
metallic to even bio-degradable (Katzen p941-42).
The Double-helix Spiral Prosthesis, developed out of the Mass
group's early spring coil design, was the first expandable stent used clinicly.
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It was a steel double-helix spring that was mounted on a flexible delivery
instrument (Zollikofer p273).When released, it expanded under its own
force, opening the lumen. TheWallstent, which has been used clinically
since 1986 in both coronary and peripheral arteries is made of stainless-steel
filaments woven into a tubular criss-cross pattern. Because none of the fila
ments are soldered were they cross, it is fully flexible. When mounted on the
introducer, it is stretched longitudinally, subsequently decreasing its diame
ter.When released at the site of the occlusion, it rebounds to its natural
shorter, wider shape forcing the lumen open (Zollikofer p 276). Another
interesting development in stent technology is shape memory alloy stents,
although their development has many obstacles to overcome before clinical
use is practical. The basic premise relies on the characteristics ifNitinol, a
nickel titanium alloy. Nitinol wire is shaped in the form of a spiral and heat
ed to
500
C.When cooled it can be stretched into a straight flexible wire.
After delivery, when the Nitinol is warmed by the patients body tempera
ture, it
"remembers"
the shape at which it was heated and coils, expanding
the lumen (Zollikofer p274).
This paper will focus on the branch of stenting's developmental tree
leads to the extensively tested Palmaz Intravascular Stent, used clinicly
since 1987 (Zollikofer p274). Though, it has had limited application in the
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femoral-popliteal region, it is best suited, and most often used on iliac
lesions (Katzen p941). The design of the Palmaz stent consists of a seamless
cylinder ofmedical-grade stainless steel. The cylinder wall has parallel, stag
gered rows of slots, which allows it to expand under pressure (Palmaz p728).
Mounted on an angioplasty balloon catheter the stent is advanced percuta
neously to the site of the lesion. The balloon is inflated, and the stent
expands, opening the lumen and remaining as long term physical support
(Palmaz p728).
Before the procedure, heparin is introduced into the bloodstream
(Palmaz p728). The patient is also taking aspirin regularly for two days prior
and is asked not to eat or drink anything after midnight the night before
(Johnson&Johnson). Ankle/brachial indices and angiography are diagnostic
tools of the procedure.
The stent, unexpanded, measuring 3.1 x 30 nun is mounted on an
angioplasty ballon catheter that can be inflated to an 8mm diameter. To hold
its position on the balloon the ends of the stent are crimped with a specially
designed tool (Zollikofer p274). The stent/balloon assembly now complete, it
is introduced into the vessel in a teflon sheath through a hemostatic valve.
When treating iliac lesions, which is most commonly the case, the stent is
introduced into the femoral artery. The lesion may have been previously
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dilated through conventional PTA in order to allow the passage of the teflon
sheath across it. Once the teflon sheath is in place, the stent is advanced to
the site of the lesion (Palmaz p728). Fluoroscopic imaging allows the surgeon
to make proper placement of the stent (Johnson & Johnson). "Positioning of
the stent before expansion is accomplished with at least two of three refer
ence points as follows: bone landmarks, external metallicmarkers, and con
trast injection images either freeze frame or depicting the map of the ves
sels"
(Palmaz p728).
Once in place, the balloon is inflated, expanding the stent and the
lesion, leaving the prosthetic steel mesh flush with the lumen of the vessel.
Inflation pressure ranges from 8 to 12 atm (Palmaz p 728). The stent can
potentially expand to a diameter of 7 to 15 mm. Therefore, if it is necessary,
the original 8mm balloon may be removed and replaced with a larger bal
loon to further expand the same stent (Zollikofer p274). In the event that the
stent is not long enough to open the whole stenosis, a second stent may be
placed next to the first, overlapping it by 5-8 mm (Palmaz p728). After the
implanted stent is sufficiently expanded, as evidenced by ankle/brachial
pressure gradient measurements and angiography, the balloon is deflated
and the catheter removed. The puncture wound is controlled by manual com
pression (Palmaz p728).
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The patient is confined to bed for eight hours and may usually leave
the hospital after the next day. Follow-up exams and angiography are sched
uled.Aspirin is continued long-term (Palmaz p728).
A study, first published in 1988 and updated in 1990, headed by the
developer, Dr. Julio Palmaz, was the basis for FDA approval (Katzen p946).
The results were quite positive.Ankle/brachial indices improved directly
after stent placement. Post-procedural angiograms showed complete dilation
ofmost vessels, with "smooth, parallel
edges"
of the stent and the natural
lumen of the vessel (Palmaz p729-30).
However, although immediate post-procedural success is imperative,
the true value of stenting, and the Palmaz stent in particular, is supposed to
be long-term patency. "The promising hemodynamic and clinical results
obtained in our series of iliac stent placements may reflect the fact that most
of our patients had isolated iliac artery stenosis and good blood outflow.
Similar results may have been obtained with conventional balloon angioplas
ty in the same patients. However, on the basis of our laboratory experience,
we expect the long-term benefits to be superior in patients treated with
stents"
(Palmaz p730). Needless to say much interest exists in studying the
long-term results.
Dr. Palmaz and associates conducted a randomized trial comparing
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Patients who underwent PTA only to Patients who had stents placed with no
previous PTA. The data at 24 months shows a clear divergence of the two
groups. The stent group were observed to have patency rates 10% to15%
higher (Katzen p947).
Expectations are supported with early success more so in reference to
the Palmaz Intravascular Stent than the Auth Rotablator, but the
future ofboth technologies is still to be determined. At any rate, both are






This illustration is unique in the collection primarily because of
its origin. It was requested by Dr. Balaji as an illustration that
would be particularly useful to him, therefore it has a more distant connec
tion to the other pieces. The purpose of the illustration is to show a progres
sion of procedures, which are invasive, commonly performed prior to the
advent of intraluminal stenting, which is minimally invasive. The other pro
cedures include Thrombo-endarterectomyAorto-biiliac bypass,Aorto-
bifemoral bypass, Femmoral-femmoral bypass and axillary-femmoral bypass.
In the beginning, many layouts were created and compared to each
other. Two concepts had to be demonstrated in the illustration: first, a
chronological progression of the procedures and second, a separation
between the invasive procedures and minimally invasive stenting. Two semi
final layouts were chosen. One which showed stenting larger, to the right of
a horizontal orientation, while the invasive procedures were grouped to the
left and pictured at a lesser scale. The second design featured stenting in the
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center of a vertically oriented illustration, while the non-invasive procedures
orbited in a clockwise chronological progression. This design was ultimately
chosen. The clockwise orbit best expressed the chronological progression
and the separation of invasive and non-invasive procedures.
With a layout in mind, sketches were begun. Each procedure was
sketched separately, nearly 200% of the size that they would finally appear.
Pencil drawings were created using sketches provided by Dr. Balaji, along
with conceptual understanding of the procedure and medical reference
books. Preliminary sketches were presented for review of accuracy, until an
approved drawing was completed for each of the six procedures.
Each drawing was then ready to be inked. The sketches were taped to
a board, and piece of piece translucent of double-sided kid finish drafting
film was taped over the top. A size .000 Rapidograph drafting pen was used
to ink the general shapes. Templates and flexible curves were used for inor
ganic shapes, and organic shapes were inked freehand. A larger diameter
pen was used to add line-weight variations on inorganic shapes, and a size
.00 sable brush was used to add weight to lines defining organic shapes.
Line-weight creates a feeling of dimension to an otherwise flat medium. A
razor was used to scratch off highlights and the end of lines crossing behind
other lines. Once completed the inks were photo-statted 50% of the original
31
size. They were then cropped and layed out on drafting film in the previously
discussed "clock-wise
orbit"
design. Lines connecting the invasive procedures
were illustrated with a pen and T-square. Finally, the whole page was photo
stated at 100%.
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Palmaz Stent Cover Illustration
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This painting was done as a cover illustration for a hypothetical
informational brochure on the Palmaz Intravascular Stent.
Being cover art, it had to say many things about the procedure as a whole, a
wide commentary that could be both editorial and dramatic. This
multi-
faceted requirement was best served by a montage approach.
The focus had to be the stent itself, along with the iliac arteries, for
this is the region where it is best suited and most commonly used. X-ray
technology always a major part of the procedure, an angiogram was chosen
as a secondary image. Crediting the men and women who preform the proce
dure and also tying in to the angiographic theme, an operating room scene
was chosen as a third image. Pictured are two physicians viewing an angio
graphic monitor while inserting the catheter. Many montage sketches were
completed combining these three
elements. An early idea, included an iliac
artery coming off of an angiogram into three-dimensional reality. The final
design, however, includes an angiogram sitting below a three dimensional
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aorto-iliac region, mirroring its condition. For example, the right common
iliac is undergoing the procedure, so the corresponding artery in the
angiogram is unoccluded. Likewise, the occlusion present left side is also
reflected in the angiogram .
Once a final design and pencil drawing was completed, the drawing
was transferred to Strathmore Double weight illustration board, to begin the
final illustration which was to be a combination ofwatercolor and air brush.
A watercolor under-painting was the first step. Cool and dark prussian blue
was washed into the general areas of shadow and warm, glowing lemon yel
low was washed into areas of highlight. Little care is taken to stay between
pencil lines at this stage; letting under washes slip into other areas helps
unify a piece. No blues or yellows were washed into the operating room
scene. It was completed with a limited palette of yellow ochre and burnt
sienna in order to give it a rich amber glow while still allowing it to fall back
in the composition, so as not to compete with the stent, the primary focus of
the piece.
After the first washes dried, local colors were applied. Due to the vari
ance ofmaterials and textures different approaches were taken with each
element of the piece. The arteries were treated with washes ofWindsor
Newton light red, a color which translates the organic pinks and reds of
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human tissue remarkably well.Washes of color were left fairly loose to keep
the organic feeling in contrast with the slick manufactured texture of the
instruments. The fatty lesion in the left common iliac was treated with the
same looseness. Ochres and yellows were used to give it a yellow, fatty
appearance, and again light red was used as a unification device. Objects
pick-up colors from surrounding objects so using an arterial color helps cre
ate the illusion that the fat is sitting inside the artery.
The inorganic components, the catheter, the balloon and the stent
were treated with much more controlled, sharper washes, and, in fact, much
of their look was created with later applications of airbrushed acrylic paint.
Masking tape masks were carefully placed and cut before washes were
applied to the catheter to achieve the high-contrast, hard edged reflective
surface. The balloon was created with washes of ceurelian blue. Surrounding
colors were also washed in, and detail was faded just inside the edges of the
balloon with a rough eraser, in order to create an illusion of transparency.
Sharp highlights were applied with white gouache to represent the taut
shiny surface of an inflated balloon. The angiogram was completed with flat
washes payne's grey in a manner that would suggest the photo-negative
appearance of an X-ray.
With the watercolor washes completed and dry, the airbrush could be
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applied. The artery and the angiogram were masked-off and the background
was airbrushed with a broad covering ofBurnt sienna and prussian blue to
darken some of the washes and to unify it into one complete space, bringing
the high-contrast, high-detail elements to the forefront. More masks were
applied to the piece and cast shadows were airbrushed onto the internal
artery wall to create the illusion that the catheter, balloon, and stent are
existing in the space within the artery and to strengthen the concavity of the
artery. Next, everything was masked, and the small meshwork of the stent
was carefully cut out with a razor blade, exposing the board in only the
shape of the stent. Over this exposed mesh work, a metal cylinder was air
brushed with a hard highlight; dark, sharp core shadow and reflected light
using colors from the surrounding environment. The mask was then
removed and the cylindrical features were only left in the shape of the dia
mond-slotted stent. Lastly, lens flares were air-brushed onto the stent to
complete the illusion of reflective metal.
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Auth Rotablator Cover Illustration
38
Like its counter-part on the cover of the stenting brochure,
this illustration (for the cover of a hypothetical Rotablator
brochure) had to say many things about the procedure as a whole, being
both editorial and dramatic. Again, this was best served by a montage.
The focus had to be the technology at work in the vessel it is best suit
ed and most commonly used, in this case the femoral artery. To identify the
vessel as the femoral artery it is shown in its landmark surroundings in the
adductor canal. The artery in the illustration is running along the canal cre
ated by the vastus medialis and the adductor longus, accompanied, as in life,
by the femoral vein, the saphenous nerve, and the nerve to vastus medialis.
A human figure, grasping his thigh, with femoral arteries visible through his
transparent flesh is present in the background. The computer blips of an
ankle/brachial gradient run along the bottom in the foreground.
With a final pencil drawing complete, it was transferred to strathmore
double-weight illustration board, and the water color under painting was
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begun. Before applying any paint, thin line tape was put down as a mask in
the shape ofgradient lines in the area that the ankle/brachial blips were to
be. This allowed me to paint over this area and remove the tape after paint
ing leaving an absence of color in the shape of a graph. The first wash begins
with applications of prussian blue to the shadow areas and yellows to the
highlights. Letting the washes flow freely, not being so concerned with
boundaries of color, at this stage makes for a more unified piece in the end.
As in the cover art for the Palmaz Stent, no blues or yellows were used in
the human figures. Only ochres and siennas were used because they create a
rich but monochromatic tone as not to compete with the main focus of the
piece.
After the under washes dried, local colors were applied, and, as always
an element's surface characteristics dictated its treatment. The muscle is
fibrous and organic, so it was treated with loose washes that followed the
directions of its fibers. The right side of the vastus medialis was treated with
light red and crimson to show the reflected light present when sitting next
to a red object such as the femoral artery. Most of the muscle color is
achieved with burnt and raw sienna. Those colors give a natural muscle hue
as well as allowing the adductor longus to fade easily into the ochres and
siennas of the background and the human figure.
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Nerves were to be portrayed as whitish yellow so they had to pick up colors
from their environment. The nerve on the left was created with washes of siennas
and light red (especially in the reflected light) to create the illusion that it was in
the same space as the artery and muscle. The nerve on the right has washes of
blue in reflected light to give the illusion that it is floating over the blue femoral
vein. Yellows were applied to both nerves as they do have a subtle hue of their
own. The lesion is treated with free-flowing yellow washes to represent its fatty
make up. Siennas and reds are used as core shadow colors. The artery and vein
were treated similarly but with different color schemes. Light red andAlizarin
crimson washes make up most of the artery while prussian blue was used mostly
in the vein.
The back of the burr was painted with sharply contrasted, tight washes to
show that it is an inorganic, metal object as opposed to the many organic elements
surrounding it. The highlights on the burr pick up yellows, siennas and reds from
the surrounding environment while the reflected light glows blue because the vein
is positioned behind it. Shadows were hard, sharp and dark applications of Payne's
grey. This treatment served to create the illusion of a shiny reflective metallic sur
face. The front of the burr, with its diamond studs, was treated with the same color
scheme but softer and more broken to represent its non-uniform surface, and light
and dark specks of color were placed to represent the diamond chips. Lastly, after
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all washes were dry a rough eraser was used to remove the hard edges of
some of the washes and to strengthen some of the highlights.
Everything dry, airbrush could now be applied for the finishing touch
es. Various masks were cut so that the color could be applied selectively. The
dissected edges of muscles were darkened and solidified, and the shadows
cast onto the muscles by the artery, vein and nerve were painted in. The
femoral arteries were airbrushed into the legs of the figure in the back
ground. It is important to get the lumens of the vessels very dark, because
the contrast that is created helps give the illusion of being hollow. That con
trast is difficult to achieve with watercolor so the lumens were airbrushed.
Lens flare highlights were airbrushed onto some of the diamond chips on the
burr to give the illusion that they are catching light. Motion implying
"swooshes"
were airbrushed on the back of the burr and catheter to create
the illusion of spinning. A glow was airbrushed in the shape of the
ankle/brachial index computer blips on top of the graph, and lastly, acrylic









esigned to give simple succinct information, the orientation
drawings had to show the viewer the point of entry of the
catheter, and the anatomical destination of the catheter. It was important to
demonstrate that the stent catheter, destined for the iliacs, is introduced in
the femoral artery and is advanced crainially to the stenosis. Conversely, in
the second drawing, it was also important to stress that the Rotablator, des
tined for the superficial femoral artery, was introduced in the femoral artery
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and procedes caudally to the stenosis.
A male figure is depicted in each from head to knees. The pertinent
arteries are visible. The catheter is shown entering the femoral artery, and
the area of stenosis is highlighted with a thick circle. That circle is projected
to a larger scale over the figure's left shoulder. Inside the projection more
details can be seen: the lesion and the tip of the guide wire with an arrow
illustrating the direction of catheterization for each.
Content and layout were decided with preliminary sketches, and each
orientation piece was drawn about 200% of the size they would finally
appear.When the final drawings were approved they were inked.
The sketches were taped to a board and a translucent piece of double-
sided kid-finish drafting film was taped over the top. A .000 rapidiograph
was used to ink the general outline of all the elements, as well as for stip
pling. Circle templates and a french curve was used to ink the more precise
shapes. A .00 sable was used to add line weight where appropriate. An X-
acto knife was used to scrape off ink to depict highlights and lines passing
behind other lines.
When the originals were complete they were photo-statted at 50% to




The purpose of this collection of illustrations is to explain, in a
step by step manner, the basic concept behind Rotational
Atherectomy. The process is broken down into four main steps. First, the ves
sel is shown with the lesion in place. The next frame shows an early pass of
a small diameter burr. The third portrays a latter pass with a burr of larger
diameter, and the final illustration shows the smooth inner lumen of the ves
sel when the lesion is completely removed.
Because these illustrations had a very specific purpose -namely to
instruct- they were more direct than the cover illustrations. The information
concisely meets the objectives of the lesson at a level the learner is prepared
to understand.
Pencil sketches were completed of the four steps and presented for
approval on their accuracy. After approval, they were placed on a light table
and a piece ofwhite Color-aid paper was placed over them. The final illus
trations were to be completed with "carbon-dust". The drawings could be
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seen through the Color-aid, and they were traced lightly with a charcoal
pencil.A
"pool"
of charcoal dust was created by scratching the charcoal pen
cil on a sandpaper pad. Tone was applied to the paper by picking up dust
with a sable brush and placing it on the page, or was applied directly with
the carbon pencil itself. The brush was then used to blend the tone in the
drawing. A kneaded eraser was used to remove tone in the areas of light.
With the brush, highlights were blended on the vessel and the lesion but










Analogous to the teaching illustrations completed for Rotational
atherectomy, the purpose of this collection of illustrations was
to explain the basic concept behind the Palmaz vascular stent. This proce
dure was also translated into four major steps. First, the stent, unexpanded
and mounted on a deflated angioplasty balloon, is positioned at the site of
the stenosis. Second, as the balloon inflates it begins to expand at each end
where it encounters no resistance from the stent, and, as the pressure
increases, the stent expands from the ends inward. Third, fully expanded
under the pressure of the inflated balloon, the stent compresses and pushes
the lesion out from the center of the lumen. Fourth, with the balloon
removed, the stent remains as a prosthetic support, insuring patency.
Preliminary drawings were completed and approved. The final illus
trations were to be completed in pen and ink, but to a more complex and
developed level than the simple orientation illustrations. Double-sided kid-
finish drafting film was placed over the drawings. A .000 Rapidiograph pen
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to start some outlining and stippling. Because of the range of elements in
the illustrations and the surface qualities of each, specific pen techniques
were used to represent specific textures. The fatty lesions were stippled to
represent their soft organic mass. The vessels were completed in contour line
to reflect the concavity of the surface, and cross contour lines were added to
bring tone to the shadows. The deflated balloon was drawn with stylized,
simple line, and it was created freehand to reflect its limpness. The inflated
balloon and the stent were completed with stylized, simple line drawn with
the aid of squares, rulers, french curves, and templates to illustrate their
taut plastic or hard metallic surface qualities. Variations in line weight were
achieved with thicker pens and a .00 sable brush. An X-acto knife was used
to scratch lines crossing behind each other and also to add highlights.





ince neither series of teaching illustrations were completed in
color, these two pieces were done as color references. One step
from each series was chosen to be completed as a color reference for the set.
The first step of the stenting series and the third step of the atherec
tomy series were chosen. The drawings used to create the non-color illustra
tions were transferred to strathmore double-sided illustration board. The art
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